- Home
- NKSH vs LENZ Comparison
NKSH vs LENZ Comparison
Compare NKSH & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | LENZ |
|---|---|---|
| Founded | 1891 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.8M | 219.8M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NKSH | LENZ |
|---|---|---|
| Price | $34.80 | $7.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 25.1K | ★ 777.5K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | ★ 100.81 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | $8,176,000.00 | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $44.74 | ★ N/A |
| Revenue Growth | ★ 9.39 | N/A |
| 52 Week Low | $24.74 | $6.61 |
| 52 Week High | $40.00 | $50.19 |
Technical Indicators
Market Signals| Indicator | NKSH | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 37.13 |
| Support Level | $34.32 | $6.61 |
| Resistance Level | $38.09 | $10.42 |
| Average True Range (ATR) | 0.78 | 0.49 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 71.19 | 20.74 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.